Article
Comprehensive genotypic, phenotypic, and biochemical characterization of GOT2 deficiency: A progressive neurodevelopmental disorder with epilepsy and abnormal movements.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Dec 2025
German Hannah M, Zaki Maha S, Usmani Muhammad A, Karagoz Irem, Efthymiou Stephanie, Abdel-Hamid Mohamed S, Arabiyat Haya Abdelhafez, Ghaffar Amama, Shahzad Mohsin, van Bokhoven Hans, Ahmed Zubair M, Yaghini Omid, Hosseini Neda, Majidinezhad Maede, Alavi Shahryar, Bosma Marjolein, Broeks Melissa H, Türkdoğan Dilşad, Suri Mohnish, Laura de Godoy Laiz, Verhoeven-Duif Nanda M, Riazuddin Sheikh, Gleeson Joseph G, Alves Cesar, Jans Judith J M, Riazuddin Saima, Houlden Henry, Maroofian Reza
Abstract excerpt
PURPOSE: Glutamic-oxaloacetic transaminase (GOT), also known as aspartate aminotransferase, catalyzes the reversible transamination of oxaloacetate and glutamate to aspartate and α-ketoglutarate. Two isoforms, cytosolic (GOT1) and mitochondrial (GOT2), are integral to the malate-aspartate shuttle, a key regulator of intracellular redox homeostasis. Recently, 5 patients with biallelic variants in GOT2 were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
